Reorganization of the Office of Health Equity, 76836-76838 [2024-21411]
Download as PDF
lotter on DSK11XQN23PROD with NOTICES1
76836
Federal Register / Vol. 89, No. 182 / Thursday, September 19, 2024 / Notices
CDC pathogen-specific programs in the
evaluation of existing and in the design
of innovative and novel diagnostic tests
and assays (molecular and
immunological); (12) provides
laboratory triage capability at CDC for
unknown biological and chemical
agents; (13) produces hybridomas,
monoclonal, and polycolonal
antibodies, and in vitro diagnostic
products for diagnostic research
purposes, proficiency testing, pandemic
preparedness, outbreak response and
surveillance activities; (14) collaborates
with subject matter experts in regulatory
compliant development, production,
packaging, storing and distribution of
Biosafety Level 2 (BSL2)/Biosafety Level
3 (BSL3) reagents, select agents, novel
immuno- chemical reagents and
reference diagnostic reagents; (15)
provides dispensing, lyophilizing, label
production, and device assembly
services; (16) improves the process of
bench-top development and in-house
pilot scale production, providing
immediate availability for distribution,
preventing backorders, and streamlining
commercialization; (17) operates the
CDC Biorepository as a centralized
resource to preserve CDC’s valuable
samples and provide ongoing support to
CDC programs; (18) manages sample
collections, along with associated
information and data obtained from
CDC’s public health surveillance,
research, and outbreak responses; (19)
serves as the administrator that issues
CDC’s required standardized identifiers:
the CDC Sample Identifier and CDC
Unique Identified; and (20) provides
consultation in all of the above
technical services.
Laboratory Products and Services
Branch (CANDE). (1) maintains
laboratory water treatment systems to
ensure the quality of CDC reagent grade
laboratory water; (2) produces,
develops, evaluates, and distributes
custom microbiological and cell culture
media, buffers, chemical reagents, and
cell cultures; (3) maintains CDC’s
Biological Reference Reagent Inventory
and a serviceable inventory at the
DCLSR Continuity of Operations storage
facility; (4) packages infectious
substances, clinical specimens, and
other materials, ensuring compliance
with shipping regulations; (5) manages
all CDC exports and deemed exports
ensuring compliance with regulations
and serves as CDC liaison with
Department of Commerce for exportrelated issues; (6) coordinates laboratory
glassware and consumable stockroom
operations; and (7) provides
consultation in all of the above
technical services.
VerDate Sep<11>2014
16:59 Sep 18, 2024
Jkt 262001
Delegations of Authority
All delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Robin D. Bailey, Jr,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2024–21412 Filed 9–18–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Reorganization of the Office of Health
Equity
Centers for Disease Control and
Prevention (CDC), the Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
CDC has modified its
structure. This notice announces the
reorganization of the Office of Health
Equity (OHE). OHE abolished an office
and modified mission and function
statements.
SUMMARY:
This reorganization of OHE was
approved by the Director of CDC on
September 13, 2024, and became
effective September 13, 2024.
FOR FURTHER INFORMATION CONTACT: Kem
Williams, Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
MS TW–3, Atlanta, GA 30329;
Telephone 404–639–7199; Email:
ohepolicy@cdc.gov.
SUPPLEMENTARY INFORMATION: Part C
(Centers for Disease Control and
Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 89 FR 68442–68443,
dated August 26, 2024) is amended to
reflect the reorganization of Office of
Health Equity, Immediate Office of the
Director, Centers for Disease Control
and Prevention. Specifically, the
changes are as follows:
I. Under Part C, Section C–B,
Organization and Functions, make the
following changes:
• Update the mission for the Office of
Health Equity (CAG)
DATES:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
• Update the mission for the Office of
the Director (CAG1)
• Abolish the Office of Equitable
Population Health (CAGB)
• Update the mission for the Office of
Minority Health (CAGC)
• Update the mission for the Office of
Health Equity (CAGD)
II. Under Part C, Section C–B,
Organization and Functions, within the
Office of Health Equity (CAG), delete
the mission or function statements for
and replace with the following:
Office of Health Equity (CAG). The
Office of Health Equity (OHE) is located
in the CDC Immediate Office of the
Director and serves as principal advisor
to the CDC Director on all health equity
matters domestic and global. In carrying
out its mission, OHE: (1) leads an
agency-wide health equity strategy that
includes crosscutting multi-year
initiatives that advance comprehensive,
well-defined, and measurable health
outcomes; (2) coordinates health equity
science including advancing the
surveillance of health equity indicators
and the science of achieving health
equity by consistently applying data
collection and analysis standards in
collaboration with the Office of Public
Health Data, Surveillance, and
Technology, as well as the Office of
Science; (3) coordinates programs,
practices, policies, and budget decisions
across the agency with a health equity
lens that includes a comprehensive
view of disparities (including race,
ethnicity, gender, sexual orientation,
rurality, disability) and health inequities
(e.g., social determinants of health); (4)
works in collaboration with CDC’s
Office of Communications to develop
and lead agency-wide communication
efforts aimed at increasing awareness,
transparency, language access, and
cultural responsiveness; disseminate
scientific and programmatic findings to
the public; and foster synergy amongst
CDC health equity initiatives; (5) shares
best practices, coordinates, collaborates,
and collectively advances health equity
standards and principles in science,
programs, and in communications with
the public and our partners; (6) leads
and supports a health equity approach
for emergency responses across the
agency that includes working with
partners to reach communities that are
underserved and subject to largely
preventable health disparities and
health-related needs; and (7) applies an
intersectionality lens to addressing
health disparities by working across
units within OHE and CIOs to increase
program efficacy closing gaps that
perpetuate disparities and inequities.
Office of the Director (CAG1). The
Office of the Director provides
E:\FR\FM\19SEN1.SGM
19SEN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 182 / Thursday, September 19, 2024 / Notices
leadership, oversight, fiscal
management, and coordination to all
units within the Office of Health Equity,
including leading and coordinating the
planning and implementation of an
agency-wide strategy to address largely
preventable health disparities and
health inequities among persons with
disabilities, people who identify as
LGBTQ+, and people who live in rural
and frontier communities. The Office of
the Director ensures collaboration
through a matrix management approach
across all units within OHE to achieve
an intersectional approach to reducing
health disparities in populations that
have experienced persistent patterns of
poor health outcomes. Further, the
Office of the Director: (1) drives
Executive accountability and responsive
decision-making relevant to health
equity at all levels; (2) ensures agencywide health equity approaches through
the development of key deliverables and
indicators (e.g., standardized
documents, processes, policies, and
practices that advance health equity); (3)
incorporates health equity into existing
and future agency policies and programs
building on current efforts that have
been effective in achieving equity; (4)
leads the advancement of intersectional
health equity practices and principles
across the agency; (5) leads efforts to
build agency-wide competency in
health equity and social determinants of
health (SDOH) that effectively support
cross-cutting equity considerations for
both ongoing activities and during
emergency response-related efforts; (6)
leads and contributes technical
expertise to the development of training
materials which will support a cadre of
professionals who will assist in
emergency response work and who have
expertise related to disproportionately
affected communities (e.g., racial and
ethnic minority populations, people
with disabilities, and non-U.S. born
persons), prioritizing individuals who
can assist in a culturally responsive and
linguistically appropriate manner and
who would easily be able to engage with
appropriate community leaders in the
response; (7) serves as the primary point
of contact for efforts across the CDC’s
ecosystem to develop and share best
practices, coordinate, collaborate, and
collectively advance health equity
standards and principles in science,
programs, and in communications with
the public; and (8) proactively fosters
community engagement with existing
partners, STLT health departments,
engagement with people with lived
experience from disproportionately
affected communities and strengthen
VerDate Sep<11>2014
16:59 Sep 18, 2024
Jkt 262001
relationships with national and
community-based organizations (CBOs).
Office of Minority Health (CAGC).
Office of Minority Health (OMH) (1)
promotes public health research,
evidence-based programs, policies, and
strategies to improve the health and
well-being of racial and ethnic minority
populations; (2) focuses on the
collective goal of the success,
sustainability and dissemination of
health equity promoting policies,
programs, and practices; (3) provides
subject matter expertise to the Office of
Health Equity in areas that are related to
racial and ethnic minority health; (4)
works in a coordinated manner with the
Office of Women’s Health (OWH) to
ensure an intersectionality lens is
applied to the work to improve the
health and well-being of people who
identify with a racial and/or ethnic
population as well as other identity
groups such as people with disabilities;
(5) applies an intersectionality lens,
contributes subject matter expertise to
the development of guidance documents
and standards related to improving
minority health; (6) applies an
intersectionality lens, partners with
CIOs to implement and refine how
health equity approaches related to
minority health are operationalized and
institutionalized; (7) contributes
technical expertise to the development
of quantitative and qualitative
indicators and metrics needed to assess
minority health and associated health
inequities; (8) partners with CIOs to use
standardized tools and metrics relevant
to minority health to monitor progress,
measure effectiveness, and make
changes to improve health outcomes; (9)
contributes technical expertise to the
development of minority health and
equity-related technical communication
products (e.g., white papers, technical
briefs, success stories); (10) provides
thought leadership and technical
consultation in the science and practice
of minority health, health equity, and
the elimination of health disparities;
(11) applies an intersectionality lens,
contributes technical expertise in
minority health to agency-wide
communication efforts aimed to
increase awareness of CDC’s equity
approaches and infuse those approaches
into CDC’s public health work; (12)
supports the Chief Health Equity Officer
(CHEO) unit during emergency
responses; and (13) assists the
Immediate Office of the Director, as
needed, to identify and develop
partnerships with STLTS health
departments, minority health-focused
national and CBOs.
Office of Women’s Health (CAGD). (1)
promotes public health research,
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
76837
evidence-based programs, policies, and
strategies to improve the health and
well-being of women and girls; (2)
serves as a central point for women’s
health and raises visibility of risk factors
and other conditions that impact
women’s and girls’ health; (3) provides
subject matter expertise to support
gender and women’s health and
collaborates with OMH to develop a
whole of public health approach while
contributing to and supporting the work
of OHE/OD; (4) applies an
intersectionality lens, contributes
subject matter expertise to the
development of guidance documents
and standards related to women’s
health; (5) applies an intersectionality
lens when partnering with CIOs to
implement and refine how health equity
approaches related to women’s health
are operationalized and
institutionalized; (6) contributes
technical expertise to the development
of quantitative and qualitative
indicators and metrics needed to assess
women’s health; (7) partners with CIOs
to use standardized tools and metrics
relevant to women’s health to monitor
progress, measure effectiveness, and
make changes to improve health equity
outcomes; (8) contributes technical
expertise to the development of
women’s health and equity-related
technical communication products (e.g.,
white papers, technical briefs, success
stories); (9) contributes technical
expertise in women’s health to agencywide activities that include (a)
developing and disseminating key
guidance documents, where needed,
that address social and structural
determinants of health; (b) advancing
the surveillance of health equity
indicators and the science of achieving
gender health equity; and (c)
consistently applying data collection
and analysis standards in collaboration
with the Office of Public Health Data,
Surveillance, and Technology and the
Office of Science; (10) applies an
intersectionality lens, contributes
technical expertise in women’s health to
agency-wide communication efforts
aimed to increase awareness of CDC’s
gender equity approaches and infuse
those approaches into CDC’s public
health work; (11) applies an
intersectionality lens to technical
expertise in the design of training
programs and technical assistance
efforts implemented with CIOs,
programs, partner organizations, and
communities; and (12) assists the OHE
Office of the Director, as needed, on
partnership development and
community engagement efforts,
E:\FR\FM\19SEN1.SGM
19SEN1
76838
Federal Register / Vol. 89, No. 182 / Thursday, September 19, 2024 / Notices
including for emergency response
events.
III. Under part C, Section C–B,
Organization and Functions, delete the
respective mission or functional
statements for and replace with the
following:
Meningitis, Pertussis, and Diphtheria
Epidemiology Branch (CJEC). (1)
provides epidemiologic subject matter
expertise and technical assistance for
surveillance, prevention, and control of
bacterial illness, including
meningococcal disease, Haemophilus
influenzae disease, diphtheria,
pertussis, tetanus, and bacterial
meningitis syndrome; (2) develops,
implements, and evaluates prevention
strategies for these bacterial diseases,
including vaccine and non-vaccine
strategies; (3) supports development of
vaccine policy through the ACIP
process; (4) conducts surveillance and
epidemiological research for
meningococcal disease, H. influenzae
disease, diphtheria, pertussis, tetanus,
and bacterial meningitis syndrome; (5)
provides consultation and support to
domestic and international partners on
the use of vaccines and other prevention
measures for bacterial respiratory
diseases; and (6) collaborates with other
CDC groups, other federal agencies,
state, tribal, local, and territorial groups,
ministries of health, World Health
Organization, private industry,
academia, and other governmental and
non-governmental organizations
involved in public health.
Delegations of Authority
All delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
Robin D. Bailey,
Chief Operating Officer, Centers for Disease
Control and Prevention.
lotter on DSK11XQN23PROD with NOTICES1
BILLING CODE 4163–18–P
VerDate Sep<11>2014
16:59 Sep 18, 2024
Jkt 262001
Centers for Medicare & Medicaid
Services
[CMS–1823–N]
Medicare Program; Public Meeting for
New Revisions to the Healthcare
Common Procedure Coding System
(HCPCS) Coding—November 6–8, 2024
Centers for Medicare &
Medicaid Services (CMS), Department
of Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice announces the
dates and times of the virtual Healthcare
Common Procedure Coding System
(HCPCS) public meeting to be held from
November 6, 2024, through November 8,
2024, to discuss CMS’ preliminary
coding, Medicare benefit category, and
payment determinations, if applicable,
for new revisions to the HCPCS Level II
code set for non-drug and non-biological
items and services, as well as how to
register for those meetings.
DATES: Virtual Meeting Dates:
Wednesday, November 6, 2024, 9 a.m.
to 5 p.m. Eastern Time (ET); Thursday,
November 7, 2024, 9 a.m. to 5 p.m. ET;
and Friday, November 8, 2024, 9 a.m. to
5 p.m. ET.
ADDRESSES: Virtual Meeting Location:
The HCPCS public meetings will be
held virtually via Zoom only.
FOR FURTHER INFORMATION CONTACT:
Sundus Ashar, (410) 786–0750,
Sundus.ashar1@cms.hhs.gov, or
HCPCS@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
(Authority: 44 U.S.C. 3101)
[FR Doc. 2024–21411 Filed 9–18–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
On December 21, 2000, Congress
enacted the Medicare, Medicaid, and
the Children’s Health Insurance
Program (CHIP) Benefits Improvement
and Protection Act of 2000 (BIPA) (Pub.
L. 106–554). Section 531(b) of BIPA
mandated that the Secretary establish
procedures that permit public
consultation for coding and payment
determinations for new durable medical
equipment (DME) under Medicare Part
B of title XVIII of the Social Security Act
(the Act). In the November 23, 2001,
Federal Register (66 FR 58743), we
published a notice providing
information regarding the establishment
of the annual public meeting process for
DME.
In 2020, we implemented changes to
our HCPCS Level II coding procedures,
including the establishment of quarterly
coding cycles for drugs and biological
products and biannual coding cycles for
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
non-drug and non-biological items and
services.
In the December 28, 2021, Federal
Register (86 FR 73860), we published a
final rule that established procedures for
making Medicare benefit category and
payment determinations for new items
and services that are DME, prosthetic
devices, orthotics and prosthetics,
therapeutic shoes and inserts, surgical
dressings, or splints, casts, and other
devices used for reductions of fractures
and dislocations under Medicare Part B.
II. Public Meeting Agendas
Prior to registering to attend a virtual
public meeting, all potential
participants and other attendees are
advised to review the public meeting
agendas at https://www.cms.gov/
Medicare/Coding/MedHCPCSGenInfo/
HCPCSPublicMeetings, which identify
CMS’ preliminary coding, Medicare
benefit category, and payment
determinations, if applicable, and the
date each item will be discussed. In
establishing the public meeting agendas,
CMS may group multiple, related code
applications under the same agenda
item.
III. Virtual Meeting Registration
The November 6, 2024 through
November 8, 2024, HCPCS public
meetings will be virtual and available
for remote audio attendance and
participation only via Zoom. The Zoom
link and registration instructions will be
posted in the Guidelines for
Participation in HCPCS Public Meetings
document on the CMS website at
https://www.cms.gov/Medicare/Coding/
MedHCPCSGenInfo/HCPCSPublic
Meetings and in an announcement on
the HCPCS General Information page at
https://www.cms.gov/medicare/codingbilling/healthcare-common-proceduresystem. The same website also contains
detailed information on how attendees
can join the virtual public meetings
using Zoom, including dial-in
information. All individuals who plan
to speak (15 or 5 minutes) at the virtual
public meetings must register by 5 p.m.
ET on October 25, 2024. All participants
and other attendees can access the
virtual public meeting through the
Zoom link, which will be posted on the
HCPCS Level II website. Attendees can
attend more than 1 day of the public
meeting.
A. Required Information for Registration
The following information must be
provided when registering to be a
speaker:
• Name;
• Company name (if applicable);
E:\FR\FM\19SEN1.SGM
19SEN1
Agencies
[Federal Register Volume 89, Number 182 (Thursday, September 19, 2024)]
[Notices]
[Pages 76836-76838]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21411]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Reorganization of the Office of Health Equity
AGENCY: Centers for Disease Control and Prevention (CDC), the
Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: CDC has modified its structure. This notice announces the
reorganization of the Office of Health Equity (OHE). OHE abolished an
office and modified mission and function statements.
DATES: This reorganization of OHE was approved by the Director of CDC
on September 13, 2024, and became effective September 13, 2024.
FOR FURTHER INFORMATION CONTACT: Kem Williams, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, MS TW-3, Atlanta, GA
30329; Telephone 404-639-7199; Email: [email protected].
SUPPLEMENTARY INFORMATION: Part C (Centers for Disease Control and
Prevention) of the Statement of Organization, Functions, and
Delegations of Authority of the Department of Health and Human Services
(45 FR 67772-76, dated October 14, 1980, and corrected at 45 FR 69296,
October 20, 1980, as amended most recently at 89 FR 68442-68443, dated
August 26, 2024) is amended to reflect the reorganization of Office of
Health Equity, Immediate Office of the Director, Centers for Disease
Control and Prevention. Specifically, the changes are as follows:
I. Under Part C, Section C-B, Organization and Functions, make the
following changes:
Update the mission for the Office of Health Equity (CAG)
Update the mission for the Office of the Director (CAG1)
Abolish the Office of Equitable Population Health (CAGB)
Update the mission for the Office of Minority Health (CAGC)
Update the mission for the Office of Health Equity (CAGD)
II. Under Part C, Section C-B, Organization and Functions, within
the Office of Health Equity (CAG), delete the mission or function
statements for and replace with the following:
Office of Health Equity (CAG). The Office of Health Equity (OHE) is
located in the CDC Immediate Office of the Director and serves as
principal advisor to the CDC Director on all health equity matters
domestic and global. In carrying out its mission, OHE: (1) leads an
agency-wide health equity strategy that includes crosscutting multi-
year initiatives that advance comprehensive, well-defined, and
measurable health outcomes; (2) coordinates health equity science
including advancing the surveillance of health equity indicators and
the science of achieving health equity by consistently applying data
collection and analysis standards in collaboration with the Office of
Public Health Data, Surveillance, and Technology, as well as the Office
of Science; (3) coordinates programs, practices, policies, and budget
decisions across the agency with a health equity lens that includes a
comprehensive view of disparities (including race, ethnicity, gender,
sexual orientation, rurality, disability) and health inequities (e.g.,
social determinants of health); (4) works in collaboration with CDC's
Office of Communications to develop and lead agency-wide communication
efforts aimed at increasing awareness, transparency, language access,
and cultural responsiveness; disseminate scientific and programmatic
findings to the public; and foster synergy amongst CDC health equity
initiatives; (5) shares best practices, coordinates, collaborates, and
collectively advances health equity standards and principles in
science, programs, and in communications with the public and our
partners; (6) leads and supports a health equity approach for emergency
responses across the agency that includes working with partners to
reach communities that are underserved and subject to largely
preventable health disparities and health-related needs; and (7)
applies an intersectionality lens to addressing health disparities by
working across units within OHE and CIOs to increase program efficacy
closing gaps that perpetuate disparities and inequities.
Office of the Director (CAG1). The Office of the Director provides
[[Page 76837]]
leadership, oversight, fiscal management, and coordination to all units
within the Office of Health Equity, including leading and coordinating
the planning and implementation of an agency-wide strategy to address
largely preventable health disparities and health inequities among
persons with disabilities, people who identify as LGBTQ+, and people
who live in rural and frontier communities. The Office of the Director
ensures collaboration through a matrix management approach across all
units within OHE to achieve an intersectional approach to reducing
health disparities in populations that have experienced persistent
patterns of poor health outcomes. Further, the Office of the Director:
(1) drives Executive accountability and responsive decision-making
relevant to health equity at all levels; (2) ensures agency-wide health
equity approaches through the development of key deliverables and
indicators (e.g., standardized documents, processes, policies, and
practices that advance health equity); (3) incorporates health equity
into existing and future agency policies and programs building on
current efforts that have been effective in achieving equity; (4) leads
the advancement of intersectional health equity practices and
principles across the agency; (5) leads efforts to build agency-wide
competency in health equity and social determinants of health (SDOH)
that effectively support cross-cutting equity considerations for both
ongoing activities and during emergency response-related efforts; (6)
leads and contributes technical expertise to the development of
training materials which will support a cadre of professionals who will
assist in emergency response work and who have expertise related to
disproportionately affected communities (e.g., racial and ethnic
minority populations, people with disabilities, and non-U.S. born
persons), prioritizing individuals who can assist in a culturally
responsive and linguistically appropriate manner and who would easily
be able to engage with appropriate community leaders in the response;
(7) serves as the primary point of contact for efforts across the CDC's
ecosystem to develop and share best practices, coordinate, collaborate,
and collectively advance health equity standards and principles in
science, programs, and in communications with the public; and (8)
proactively fosters community engagement with existing partners, STLT
health departments, engagement with people with lived experience from
disproportionately affected communities and strengthen relationships
with national and community-based organizations (CBOs).
Office of Minority Health (CAGC). Office of Minority Health (OMH)
(1) promotes public health research, evidence-based programs, policies,
and strategies to improve the health and well-being of racial and
ethnic minority populations; (2) focuses on the collective goal of the
success, sustainability and dissemination of health equity promoting
policies, programs, and practices; (3) provides subject matter
expertise to the Office of Health Equity in areas that are related to
racial and ethnic minority health; (4) works in a coordinated manner
with the Office of Women's Health (OWH) to ensure an intersectionality
lens is applied to the work to improve the health and well-being of
people who identify with a racial and/or ethnic population as well as
other identity groups such as people with disabilities; (5) applies an
intersectionality lens, contributes subject matter expertise to the
development of guidance documents and standards related to improving
minority health; (6) applies an intersectionality lens, partners with
CIOs to implement and refine how health equity approaches related to
minority health are operationalized and institutionalized; (7)
contributes technical expertise to the development of quantitative and
qualitative indicators and metrics needed to assess minority health and
associated health inequities; (8) partners with CIOs to use
standardized tools and metrics relevant to minority health to monitor
progress, measure effectiveness, and make changes to improve health
outcomes; (9) contributes technical expertise to the development of
minority health and equity-related technical communication products
(e.g., white papers, technical briefs, success stories); (10) provides
thought leadership and technical consultation in the science and
practice of minority health, health equity, and the elimination of
health disparities; (11) applies an intersectionality lens, contributes
technical expertise in minority health to agency-wide communication
efforts aimed to increase awareness of CDC's equity approaches and
infuse those approaches into CDC's public health work; (12) supports
the Chief Health Equity Officer (CHEO) unit during emergency responses;
and (13) assists the Immediate Office of the Director, as needed, to
identify and develop partnerships with STLTS health departments,
minority health-focused national and CBOs.
Office of Women's Health (CAGD). (1) promotes public health
research, evidence-based programs, policies, and strategies to improve
the health and well-being of women and girls; (2) serves as a central
point for women's health and raises visibility of risk factors and
other conditions that impact women's and girls' health; (3) provides
subject matter expertise to support gender and women's health and
collaborates with OMH to develop a whole of public health approach
while contributing to and supporting the work of OHE/OD; (4) applies an
intersectionality lens, contributes subject matter expertise to the
development of guidance documents and standards related to women's
health; (5) applies an intersectionality lens when partnering with CIOs
to implement and refine how health equity approaches related to women's
health are operationalized and institutionalized; (6) contributes
technical expertise to the development of quantitative and qualitative
indicators and metrics needed to assess women's health; (7) partners
with CIOs to use standardized tools and metrics relevant to women's
health to monitor progress, measure effectiveness, and make changes to
improve health equity outcomes; (8) contributes technical expertise to
the development of women's health and equity-related technical
communication products (e.g., white papers, technical briefs, success
stories); (9) contributes technical expertise in women's health to
agency-wide activities that include (a) developing and disseminating
key guidance documents, where needed, that address social and
structural determinants of health; (b) advancing the surveillance of
health equity indicators and the science of achieving gender health
equity; and (c) consistently applying data collection and analysis
standards in collaboration with the Office of Public Health Data,
Surveillance, and Technology and the Office of Science; (10) applies an
intersectionality lens, contributes technical expertise in women's
health to agency-wide communication efforts aimed to increase awareness
of CDC's gender equity approaches and infuse those approaches into
CDC's public health work; (11) applies an intersectionality lens to
technical expertise in the design of training programs and technical
assistance efforts implemented with CIOs, programs, partner
organizations, and communities; and (12) assists the OHE Office of the
Director, as needed, on partnership development and community
engagement efforts,
[[Page 76838]]
including for emergency response events.
III. Under part C, Section C-B, Organization and Functions, delete
the respective mission or functional statements for and replace with
the following:
Meningitis, Pertussis, and Diphtheria Epidemiology Branch (CJEC).
(1) provides epidemiologic subject matter expertise and technical
assistance for surveillance, prevention, and control of bacterial
illness, including meningococcal disease, Haemophilus influenzae
disease, diphtheria, pertussis, tetanus, and bacterial meningitis
syndrome; (2) develops, implements, and evaluates prevention strategies
for these bacterial diseases, including vaccine and non-vaccine
strategies; (3) supports development of vaccine policy through the ACIP
process; (4) conducts surveillance and epidemiological research for
meningococcal disease, H. influenzae disease, diphtheria, pertussis,
tetanus, and bacterial meningitis syndrome; (5) provides consultation
and support to domestic and international partners on the use of
vaccines and other prevention measures for bacterial respiratory
diseases; and (6) collaborates with other CDC groups, other federal
agencies, state, tribal, local, and territorial groups, ministries of
health, World Health Organization, private industry, academia, and
other governmental and non-governmental organizations involved in
public health.
Delegations of Authority
All delegations and redelegations of authority made to officials
and employees of affected organizational components will continue in
them or their successors pending further redelegation, provided they
are consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Robin D. Bailey,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-21411 Filed 9-18-24; 8:45 am]
BILLING CODE 4163-18-P